These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 104554)

  • 1. Clinical and biochemical pathophysiology of ataxia in the sphingolipidoses.
    Philippart M
    Adv Neurol; 1978; 21():131-49. PubMed ID: 104554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biochemistry of sphingolipid storage diseases.
    Sandhoff K
    Angew Chem Int Ed Engl; 1977 May; 16(5):273-85. PubMed ID: 406814
    [No Abstract]   [Full Text] [Related]  

  • 3. [Phenotypes in heteroglycanoses and sphingolipidoses (author's transl)].
    Gehler J
    Monatsschr Kinderheilkd; 1981 Nov; 129(11):610-20. PubMed ID: 6798422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoprotein catabolism in brain tissue in the lysosomal enzyme deficiency diseases.
    Brunngraber EG; Davis LG; Javaid JI; Berra B
    Adv Exp Med Biol; 1976; 68():31-48. PubMed ID: 820170
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipid storage disease: Part II. Ultrastructural pathology of lipid storage cells in sphingolipidoses.
    Takahashi K; Naito M
    Acta Pathol Jpn; 1985 Mar; 35(2):385-408. PubMed ID: 2992227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosomal storage diseases.
    Glew RH; Basu A; Prence EM; Remaley AT
    Lab Invest; 1985 Sep; 53(3):250-69. PubMed ID: 2993742
    [No Abstract]   [Full Text] [Related]  

  • 7. Basic findings and current developments in sphingolipidoses.
    Pilz H; Heipertz R; Seidel D
    Hum Genet; 1979 Mar; 47(2):113-34. PubMed ID: 108196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Procedure for the diagnosis of sphingolipidoses or allied diseases in adult patients with neurological or psychiatric symptoms (author's transl)].
    Pilz H; Heipertz R; Seidel D
    Nervenarzt; 1979 Dec; 50(12):749-61. PubMed ID: 94938
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic disorders of lysosomes.
    Hirschhorn R; Weissmann G
    Prog Med Genet; 1976; 1():49-101. PubMed ID: 180565
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cell and disease. V. Pathology of lysosomes].
    Reuser AJ
    Ned Tijdschr Geneeskd; 1993 Oct; 137(40):2028-34. PubMed ID: 8413717
    [No Abstract]   [Full Text] [Related]  

  • 11. Mass spectrometry in the study of lysosomal storage disorders.
    Meikle PJ; Fuller M; Hopwood JJ
    Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):769-77. PubMed ID: 14528914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrafamilial variability in lysosomal storage diseases.
    Zlotogora J
    Am J Med Genet; 1987 Jul; 27(3):633-8. PubMed ID: 3115101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical, preclinical and prenatal diagnosis of congenital sphingolipidoses by determining lysosomal hydrolases (author's transl)].
    Pilz H; Heipertz R; Seidel D
    Fortschr Neurol Psychiatr Grenzgeb; 1978 Apr; 46(4):207-21. PubMed ID: 417009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research update on lysosomal disorders with special emphasis on metachromatic leukodystrophy and Krabbe disease.
    Wenger DA
    APMIS Suppl; 1993; 40():81-7. PubMed ID: 8311994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathobiochemical aspects of lysosomal enzymes with special reference to lysosomal storage diseases (author's transl)].
    Kresse H
    Wien Klin Wochenschr; 1978 May; 90(10):325-32. PubMed ID: 418578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prenatal diagnosis of incurable familial metabolic diseases. Prenatal diagnosis of disorders of lipid metabolism].
    Harzer K
    Med Welt; 1979; 30(48):1810-6. PubMed ID: 42836
    [No Abstract]   [Full Text] [Related]  

  • 17. The cerebral lipidoses.
    Malone MJ
    Pediatr Clin North Am; 1976 May; 23(2):303-26. PubMed ID: 818606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemistry of glycosphingolipid storage disorders: implications for therapeutic intervention.
    Aerts JM; Hollak C; Boot R; Groener A
    Philos Trans R Soc Lond B Biol Sci; 2003 May; 358(1433):905-14. PubMed ID: 12803924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Enzyme diagnostics in lysosomal diseases with emphasis on sphingolipidoses].
    Dreyfus JC; Poenaru L
    Arch Fr Pediatr; 1975; 32(6):503-14. PubMed ID: 810108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentrations of an activator protein for sphingolipid hydrolysis in liver and brain samples from patients with lysosomal storage diseases.
    Inui K; Wenger DA
    J Clin Invest; 1983 Nov; 72(5):1622-8. PubMed ID: 6415115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.